Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Verónica Wolff"'
Autor:
Leandro Fassola, Ivette Buendía-Roldán, Jorge Rojas-Serrano, María Laura Alberti, Felipe Reyes, Matias Florenzano, Fabian Caro, Ernesto Juárez-León, Verónica Wolff, Gabriel Carballo, Francisco Paulin
Publikováno v:
Reumatología Clínica. 18:293-298
Background and objectives ILD patients can be positive to highly specific autoantibodies of connective tissue diseases (CTD). Among them stand out myositis-specific and associated autoantibodies (MSA/MAA). There is limited knowledge about treatment r
Autor:
V Matías Florenzano, C Viviana Balboa, B Alexis Peralta, C Juan Ignacio Méndez, C Juan Carlos Maya, C Felipe Reyes, G María Carolina Cuellar, C Verónica Wolff
Publikováno v:
Revista chilena de enfermedades respiratorias. 36:254-259
Introduction: The most common extramuscular manifestation of the idiopathic inflammatory myopathies (IIM) is interstitial lung disease (ILD) and the diagnosis is based on serum autoantibodies. The new specific and associated antibodies to IIM have he
Publikováno v:
Revista médica de Chile v.148 n.11 2020
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Giant cell arteritis (GCA) is a primary granulomatous systemic vasculitis involving the aorta and its main branches that affects people aged over 50 years with a genetic predisposition. Its main phenotypes are cranial and extracranial involvement, wi
Autor:
L Omar Valenzuela, C Verónica Wolff
Publikováno v:
Revista chilena de enfermedades respiratorias. 35:278-281
Connective Tissue Diseases (CTD) comprise a heterogeneous group of multisystemic pathologies of autoimmune origin. Interstitial lung disease (ILD) associated with CTD (CTD-ILD) is common and and it worsens the prognosis of CTD. CTD-ILD represent appr
Publikováno v:
Rare ILD / DPLD.
Introduction: ILD is a frequent extra-articular manifestation of RA and explains for much of the morbidity and mortality. The aims of our study is to describe clinical, functional features of patients with RA-ILD and the variables associated with poo
Autor:
Hugo Valenzuela, Alvaro Undurraga, Verónica Wolff, Cristina Fernández, Matias Florenzano, Juan Carlos Rodríguez, Mauricio Salinas
Publikováno v:
Revista médica de Chile v.147 n.11 2019
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Interstitial lung diseases are a broad, diverse, challenging group of diseases, most of them chronic whose prognosis is not good. In the last two decades there have been considerable advances in the knowledge of the epidemiology, pathological and gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e193ef9691620e0891b40dcddf2abaa
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019001101458
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019001101458
Autor:
Leandro Fassola, María Laura Alberti, Mayra Mejía, Francisco Paulin, Gabriel Carballo, Verónica Wolff, Matias Florenzano, Felipe Reyes, Ernesto Juarez Leon, Fabian Caro, Jorge Rojas Serrano, Víctor Leiva V
Publikováno v:
ILD/DPLD of known origin.
Introduction: Insterstitial lung disease (ILD) is a frequent manifestation in patients with myositis related antibodies (MRA) with impact in the evolution. Prognostic factors have been described but we don’t have information about the behaviour of
Autor:
Tamara Palavecino, Ivette Buendia Roldán, María Laura Alberti, Matias Florenzano, Francisco Paulin, Leandro Fassola, Juan Carlos Rodríguez Díaz, José Ernesto Juárez León, Fabian Caro, Jorge Rojas Serrano, Felipe Reyes, Mayra Mejía, Verónica Wolff, Gabriel Carballo
Publikováno v:
ILD/DPLD of known origin.
Autor:
Laura Alberti, Jorge Rojas Serrano, Verónica Wolff, Fabian Caro, Francisco Paulin, Felipe Reyes, Víctor Leiva V, Ivette Buendia, Matias Florenzano, Mayra Mejía, Ernesto Juarez, Leandro Fassola
Publikováno v:
ILD/DPLD of known origin.
Introduction: ILD is a common manifestation of patients with myositis related antibodies (MRA). The aim of our study is to describe the clinical and radiological features of a group of patients with ILD and MRA, and their association with the initial
Autor:
Luis Toro, Felipe Reyes, Verónica Wolff, Juan Diego Maya, Alexis Peralta, Carolina Cuellar, Viviana Balboa, Matias Florenzano
Publikováno v:
ILD/DPLD of known origin.
Introduction: Myositis related antibodies (MRA) are helpful in the study of patients with idiopathic inflammatory myopathies (IIM), but their role in patients with interstitial lung disease (ILD) is unclear. The aim of this study is to assess whether